chrisvoncsefalvay/vaers-outcomes huggingface dataset:
He came to the hospital with a chief complaint of progressive worsening generalized weakness for 3-4 days.  Patient is extremely hard of hearing.  Currently is COVID positive and in isolation.  Wife is also in the emergency room.  Currently no family member at the bedside.  History taking from the patient was limited.  History was also obtained from the emergency room provider and the previous medical records.  Patient reports that his wife was progressively having worsening headaches and sickness and fever and she was unable to take care of him.  Also patient was having worsening generalized weakness and intermittent subjective fevers.  He also had some 3-4 episodes of loose watery stool. 11/02/2021 tested positive. He came to the hospital with a chief complaint of progressive worsening generalized weakness for 3-4 days.  Patient is extremely hard of hearing.  Currently is COVID positive and in isolation.  Wife is also in the emergency room.  Currently no family member at the bedside.  History taking from the patient was limited.  History was also obtained from the emergency room provider and the previous medical records.  Patient reports that his wife was progressively having worsening headaches and sickness and fever and she was unable to take care of him.  Also patient was having worsening generalized weakness and intermittent subjective fevers.  He also had some 3-4 episodes of loose watery stools which was the reason to come to the hospital for further evaluation and treatment.  He denies any other symptoms like cough, shortness of breath, abdominal pain, nausea, vomiting, burning or painful urination.
Patients vaccination was routine and had no notable abnormalities. Said he had a sore arm with the first and that was it and had no other vaccinations or new treatments since first shot. He was doubled over in abdominal pain starting Monday 9/6/2021 at 9pm. According to his mother he never complains about pain and she is not sure it related to the vaccination at all but reporting in case. He was seen at Hospital ED and admitted to have his appendix removed today (9/7/2021).
I'm feeling totally fine while having a conference call thru TEAMS at my home around 3:30PM on April 12, 2021. Then suddenly I felt a severe headache (as if my head was shot by a gun) at the center of my forehead. This is only the first time I felt that kind of headache. However, it only lasted for about 5-10 secs for that severe pain then after that i just felt dizzy for about 20 mins. Since then, I'm fine now and hoping that I will not feel that same pain again.
1/30/2021 Began with spiking BP and extreme pain in right shoulder - taken to ER.  Given pain med, BP came down and sent home.  2/2/2021 - Spiking BP and chest pain, numbness and tingling in hands and feet. - taken to Medical Center.  Admitted.  Series of heart and brain assessments done.  Each day he got weaker until he could no longer stand, walk, arm and hand strength depleted and dexterity issues.  Spinal Tap on  2/8/2021 revealed Guillain Barre Syndrome 2/12 Admitted to Rehabilitation Center, 2/15 at Hospital plummeting BP, 2/18 return to  Rehabilitation Center
This case was reported by a consumer and described the occurrence of dizziness in a female patient who received FLUARIX QUADRIVALENT 2018-2019 season) for prophylaxis. On 3rd October 2018, the patient received FLUARIX QUADRIVALENT 2018-2019 season. On 4th October 2018, 1 days after receiving FLUARIX QUADRIVALENT 2018-2019 season, the patient experienced dizziness, chills, fever and swelling arm. On an unknown date, the outcome of the dizziness, chills, fever and swelling arm were unknown. The reporter considered the dizziness, chills, fever and swelling arm to be probably related to FLUARIX QUADRIVALENT 2018-2019 season. Additional details were reported as follows: The age at vaccination was not reported. The patient experienced dizzy, chills, slight fever and arm was swollen. The patient stated that, she would inform her oncologist about the adverse events. The patient was also suggested, to contact the GlaxoSmithKline health center where the patient was vaccinated.
Swelling, redness, and heated area on upper arm On Friday, 09/17 developed cellulitis of upper arm.  Pain in armpit (both) and appearance of dark bruises.  On Sun 9/19 extreme fatigue and shortness of breath On Mon 9/20 cold symptoms, sinus pressure, and fatigue
4/8 Headache, followed by upset stomach and mild fever. Followed by throwing up every 30-60 minutes from 05:00 4/9 to 21:00 4/9
Prior to leaving exam room, pt complained of itching on the leg where PROQUAD was administered. Redness extending approx. 3 inches surrounding the injection site and it appeared as though a raised area of approx 1 inch. Cold pack was applied, given BENADRYL.
4-5 hr p/vax pt turned pale lasting for 30-60 second & muscle tone diminished;
This spontaneous report as received from a pharmacist refers to a male patient of unknown age. The patient received his first dose of GARDASIL (route, dose and lot # were unknown) on an unspecified date one year ago (in 2012) and now stated he would like to receive the second and third doses. No other co-suspects were reported. No concomitant medications were reported. No adverse symptoms reported. The outcome of the event is unknown.
Nine days post vax the patient developed a case of varicella, greater than 100 lesions over her face and trunk.
Information has been received from a registered nurse via Poison & Drug Center referring to a 4 year old female patient. The patient's medical history included a 10-day antibiotic course completed on an unknown date over 5 weeks before her visit to the clinic for an unknown indication. On 25-NOV-2016, the patient was vaccinated with a dose of PROQUAD 0.5 ml, subcutaneously, lot # M022402, expiration date 01-NOV-2017 (anatomical location was not reported), for routine health care. The dose of vaccine had undergone a temperature excursion. The patient had no concomitant medications. The patient had no laboratory values. The patient did not experience an adverse reaction and no treatments were provided. At the time of 29-NOV-2016, it was unknown if the patient continued to receive VARIVAX. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1612USA000108: US-009507513-1612USA000002: US-009507513-1612USA000174:
This case was reported by a other health professional via sales rep and described the occurrence of needle injury in a patient who received RABAVERT. On an unknown date, the patient received RABAVERT. On an unknown date, immediately after receiving RABAVERT, the patient experienced needle injury. On an unknown date, the outcome of the needle injury was unknown. It was unknown if the reporter considered the needle injury to be related to RABAVERT. Additional details were provided as follows: The age at vaccination was not reported. The reporter was made aware by a pharmacy buyer at a hospital that the patient was stuck with a vaccine needle. It was unknown if the needle stick occurred after administration or prior to that. The nurse from infection control had advised not to administer with the provided 25 gauge needle provided with the vaccine, but was not this case with this particular patient that experienced the needle stick injury. The agency reported because this occurred at a facility and the report had probably already been shared with agency, but it was not known for sure. The original email came from an Infection Control nurse. The email had been forwarded to GlaxoSmithKline QA department, but a QA had not been filed. The email stated that, they recently had a needle stick associated with the RABAVERT vaccine kit made by GlaxoSmithKline. The kit contained the vaccine, a 21 gauge needle for reconstitution and a 25 gauge needle for administration. The problem was the 25 gauge needle was not safety engineered. The nurse instructed the staff to discard the needle and replace it with a 25 gauge safety needle from their supply. However she was concerned about any manufacturer would place a non-safety needle in a kit when the standard forbids their use. She enquired if there was a kit that contains the safety needles for injection and whether there another manufacturer who provides such a kit.
Critical level INR (5.6) without cause after stable anti coagulation therapy and no additional changes in diet, disease, etc.
pt recv vax 12NOV96 & it was reported that 2wk post vax pt exp soreness @ the gluteal site of inj;1mo post vax it was reported that the exp indentation @ the inj site;pt loosing muscle mass & is c/o muscle weakness in thigh;
The injection site seemed inappropriately high in the shoulder/deltoid.  No aspiration attempted. I had a dripping sweat occur at the five to fifteen minute range. There was a flushing sensation during this. After a few minutes, it all abaited. The bandaid was saturated with blood.  My arm was never sore and I had zero symptoms after the initial reaction. I believe this injection was given intravascularly.  I have not been able to find ANY information to address the effectiveness of this route if administration and I seriously fear that I am not covered.
Patient received 2nd COVID vaccine 1 week ago and had a migraine since that day.  Came to ER for evaluation.
Pt recvd a series of 3 Engerix-B vax 27APR90, 31MAY90, 25OCT90; 6MAR91 titer for Anti-HBS was 5; 4th Engerix-B given 25MAR91;
Hives on face and arm; Fever of 102 F; Flu like symptoms; This is a spontaneous report from a contactable consumer, the patient. An 18-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0173) via an unspecified route of administration in the left arm on 09May2021 at 13:30 (at the age of 18-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8729), via an unspecified route of administration in the left arm on 19Apr2021, at 13:30, (at the age of 17-years-old) as a single dose for COVID-19 immunisation. On 10May2021 at 01:00, the patient experienced hives on face and arm, fever of 102 F (Fahrenheit) and flu like symptoms. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care.  Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events hives on face and arm, fever of 102 Fahrenheit and flu like symptoms were resolved on unknown date in May2021.  No follow-up attempts are needed. No further information is expected.
Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications information was not reported. The reporter stated that because their facility has not been able to download the digital data logger, they have been put on hold by the State at the moment and cannot administer the Moderna COVID-19 vaccine to patients until an assessment by the State was made.  There had been no power outages that would have impacted the Moderna vaccine. However, she reiterates that because her facility was unable to download the digital data logger, they would need to treat this issue as a temperature excursion.  Reporter stated that no adverse reactions were reported by any patients. No treatment medication were provided.
Pfizer on 3/8 and 3/29. Positive on 9/2 ADMITTED 8/28 TO CURRENT
My lymph above my breast on left side became sore and it became difficult to take a deep breath. A couple of days later, the pain continued over to my right side also and same difficulty getting a deep breath. For awhile, the pain was in my right armpit too. Put warm compresses on areas and it helped a bit. My sister looked up info on the internet and found that ?Aleve? might help the pain, which it did. Called the  doctor?s office and they were not very helpful. The information my sister got from the internet was of more help. The difficulty getting a deep breath lasted 2 weeks.
HD went to local detention center to administer vaccines. Pt came to clinic to recieve second dose of Pfizer. Staff unaware that patient had recieved a dose of Jansen previously on 4/6/2021. Pt educated to not recieve any further doses of COVID-19 vaccines.
RIGHT DELTOID RED HOT TO TOUCHM NO FEVER, NO PAIN. PATIENT EATING AND SLEEPING HABITS HAVE NOT CHANGED AT ALL. CHILD SEEMS TO BE FINE OTHER THAN SWELLING TO RIGHT DELTOID AND SOME DISCOMFORT. PATIENT WAS GIVEN 5TH DTaP.
positive COVID-19 test; positive COVID-19 test; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP).  A 61-year-old female patient received BNT162b2 (BNT162B2), in 2021 as dose 1, single (Batch/Lot number: unknown), in 2021 as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 28Jun2022, outcome "recovering" and all described as "positive COVID-19 test". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (20May2021) Negative, notes: Patient previously had a negative COVID-19 test result on 20May2021; (28Jun2022) Positive.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Redness, a little swelling, arm very sore cannot raise it. Pt went to MD and received antibiotics (Cephalexin)
Narrative: Patient report lightheadedness following administration of first dose of Pfizer vaccine. Patient was observed and then able to leave with no intervention.
At about 4pm, started to get migraine, neck pain, both sides of head. Took Tylenol. I was at work, finished shift. 12/17/2020  - 12/18/2020 still have migraine, both sides; 'feels different'.   History of migraines.   If worsens refer to ER
while administering Smallpox vaccine, pt felt a small drop of fluid enter her right eye.
.  Received her second dose Pfizer vaccine (LOT#: EW0185 EXP: 8/2021) at 1424 on 5/19/21. Patient alerted , EMT at 1438. Patient stated that she felt chest pain and felt dizzy. Patient stated that her chest pain was a 6/10 on the pain scale. Patient was asked to stay another 30 minutes for observation. Patient agreed.  EMT took patients vital signs at 1440. BP:180/100, pulse: 97, O2: 96%. Patient was given water. EMT retook patients vital signs and reassessed patient at 1450. BP: 120/70, pulse: 85, O2: 98%. Patient stated chest pain went down to a 4/10 with no dizziness. EMT retook and reassessed patient at 1510. Patient stated that she no longer had any chest pain. Patient stated that she had a weird feeling in her head. Patient stated that she was not dizzy and did not have a headache. Patient stated that she had eaten breakfast at 1000. Patient completed observation time. PHN educated patient on worsening signs and symptoms on side effects of the vaccine and when to contact EMS or go to emergency room/urgent care. Patient verbalized understanding of education. Patient left vaccination site unassisted and with a steady gait at 1515.
Tonic Clonic Seizure, one hour duration (7 month old). Findings:  Cranial Calcifications, cerebral atrophy. Per 214101, developmental delay, seizures, atrophy in brain. Acknowledgement letter states pt has not recovered. Severe encephalopathy, global dysfunction
injection site itchiness; mild rash on injection arm covering 3inx3in area around injection site; This spontaneous case was reported by an other and describes the occurrence of VACCINATION SITE PRURITUS (injection site itchiness) and VACCINATION SITE RASH (mild rash on injection arm covering 3inx3in area around injection site) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M20A and 031L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (injection site itchiness) and VACCINATION SITE RASH (mild rash on injection arm covering 3inx3in area around injection site). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency and CROTAMITON (ANTI ITCH CREAM [CROTAMITON]) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PRURITUS (injection site itchiness) and VACCINATION SITE RASH (mild rash on injection arm covering 3inx3in area around injection site) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were given Treatment information was provided as tylenol, iced injection site and used anti-itch cream to help relieve symptoms  Patient reports getting 2nd dose of Moderna Covid-19 Vaccine on 10Mar2021. Patient reports getting vaccination at pharmacy. Patient experienced injection site itchiness, mild rash on injection arm covering 3inx3in area around injection site. Symptoms started a few days after vaccination 12Mar2021 and are ongoing.
9MAY96 8 days p/vax pt had sz w/t102.3, fussy;during the day felt a little warm;when awoke from nap screamed a terrible cry;body went limp, eyes set to side whole body jerking;911 called;given med had resp arrest;put on ventilator;sta
Received Flu vaccine 10/17/2018 - No redness/swelling/bruising/soreness experienced initially for the first week but on 10/24/2018 developed soreness of the left anterior deltoid and bicep. He stated that he did pick of firewood and has blown leaves at the time the soreness developed. Client stated, "Unsure if it is related to straining a muscle or the flu vaccine so he wanted to report it." Has not seen a physician and has treated with over the counter medication - TYLENOL - Ibuprofen and creams without relief. Symptoms have been present for 4 weeks. 11/21/2018 - Referred to Physician for exam / Follow-up.
Patient felt dizzy/sweating, slumped to floor five minutes after administration of 2 immunizations. Returned consciousness immediately. BP 110/60, Pulse 62. Transferred to hospital for observation. Vital signs on arrival BO 128/83; Pulse 68; SP O2 97%; T-36. Discharged 6 hours later.
SYNCOPAL EPISODE (FAINTED AND FELL TO FLOOR, CAUSING LIP LACERATION AND FRACTURED TEETH), RIGORS, CHILLS, TACHYCARDIA
Ear ringing and high pitched frequencies.; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 49 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 25Mar2022 16:00 (Lot number: FK9729) at the age of 49 years as dose 3 (booster), single, administration date 15Apr2021 (Lot number: ER8731) as dose 2, single and administration date 18Mar2021 (Lot number: ER8727) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: TINNITUS (non-serious) with onset 25Mar2021, outcome "not recovered", described as "Ear ringing and high pitched frequencies.". The event "ear ringing and high pitched frequencies." was evaluated at the physician office visit. It was unknown if therapeutic measures were taken as a result of tinnitus. No follow-up attempts are possible. No further information is expected.
My son is breastfeed I received the vaccine 5/21/2021 on 6/4/2021 a rash suddenly appeared all Over his neck that was extremely itchy we treated it with steroids three days later the rash came back all over his scalp ( tiny little bumps ) again extremely itchy it went away again for theee days then returned all Over his body from head to toe , tiny pimples that were extremely itchy . This has been two for two weeks coming and going.
Headache, Diarrhea, chills, arm pain on vaccine side Narrative:
Complained of lips tingling, BP 93/66, no wheezing, sat for 15 minutes. States he is hungry because it's his lunchtime. BP 90/66. Decrease in lip tingling. Advised to return if lip tingling increases or tingling of face, by nurse, medical evaluation. Mom notified by phone.
06/27/2002- 6/29/02- Morbid swelling  and erythema to latent thigh
Pts mother was exposed to parvovirus B-19 with a positive antibody. Mother received a dose of Havrix inadvertently while infant was breast feeding. Pt was subsequently a little fussy at night for a couple of nights.
Angry, Red, raised area, hot to touch 2.5 inches by 1.5 inches, painful  treated with ice, tyenol, benedryl if needed
day 1 (Feb01) rt arm achy and sore to lift over head and first night could not sleep on rt shoulder. Slowly got better over a few days. Day 9(Feb 09) rt upper arm itchy and red blotch area about 2x2 inches. I was able to sleep on rt side that night. Day 10 (Feb 10) red blotch area  bigger about 4x4 inches and a little less itchy. I started to get concerned and google side effects and came across (covid arm) that looks like my arm.
Patient reported increased spasticity and some increased shortness of breath 1 week after receiving immunization.
Information has been received from a physician concerning a male patient in his 80's who "in the last couple of months" (approximately in 2010) was vaccinated SC with a 0.65 ml dose of ZOSTAVAX (Merck) (lot number not provided). The physician reported that "3 months after getting the vaccine" (approximately in 2010) the patient experienced a case of zoster. The physician reported that the patient was still experiencing some nerve pain. At the time of the report the patient was recovering. The patient sought unspecified medical attention. Additional information has been requested.